Why Peptides Could Become More Accessible in the U.S.
P.M. Edition for July 24. Today an FDA committee voted to increase access to six of seven peptides. Those are substances that haven’t undergone regulatory approval, but they’re promoted on social media and promise physical transformations like better skin. We hear from WSJ health and wellness reporter Alex Janin about…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from WSJ What’s News
See all episodes →Similar episodes from other shows
More like WSJ What’s News →
Peptides Are Everywhere. Businesses Are Cashing In.
Four Key Facts About Trump’s New Tariffs, and a Town Hall Showdown
The rocky legal future of Trump’s tariffs
More Trump Tariffs Are Coming
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.